A Novel Integrative Multi-Omics Approach to Unravel the Genetic Determinants of Rare Diseases with Application in Sinusoidal Obstruction Syndrome

Scientists classified 315 newly diagnosed AML patients at their center based on the expression of CD11b and CD64. The CD11b+CD64+ populations were identified as independent risk factors for overall survival and event-free survival of AML, exhibiting specific clinicopathological features.